Whether you’re visiting, celebrating something special, or just want to indulge in the cannabis world, these are the Top cannabis-friendly cities in Canada to have an amazing time. Canada is one of the two countries in the world that have completely legalized cannabis, so it’s a paradise to those who want to enjoy the plant freely and have a unique travel experience. It’s not difficult to find a cannabis dispensary in Canada, especially not in the online space. Naked Cannabis is easily one of the best! But once you have your preferred cannabis product, what should you do next? Well, you can go on a tour of the most cannabis-friendly cities in Canada and immerse yourself in the culture! To help you decide where to go, here are the top 3 cannabis cities to visit.

Cannabis Substitution Program in London since April, similar initiatives in Halifax and Vancouver

Volunteer groups in Canada are providing relief to people struggling with addiction by giving away free marijuana and cannabis edibles as a substitution for opioids. Addiction experts, however, are wary that the unproven treatment might prevent people with opioid use disorder from seeking evidence-based therapies that have proven to be effective.

In London, Ontario, volunteers with the Cannabis Substitution Program set up a table outside a church each Tuesday to distribute packages of free cannabis and edibles to people who use drugs. Members of the group maintain that high doses of THC, as much as 100 milligrams baked into an edible, can serve as a substitute for opioids and other dangerous drugs while treating the symptoms of withdrawal. 

With earnings season kicking into high gear for the cannabis industry, several companies that have reported earnings have seen volatile price swings.

Broker-dealers have been responding to the earnings reports by changing ratings and price targets on companies they respectively cover. Today, we highlighted several Canadian Licensed Producer (LPs) that have been the subject of rating and price target changes by broker-dealers so our readers can have a better understanding of the upside and downside potential associated with the new price targets. 

Canada legalized cannabis in Oct. 2018 to make money, improve public health, and help people harmed by the war on drugs. Is two out of three good enough?

So much has happened in the three years and a month since Oct. 17, 2018 that you could be forgiven for forgetting the biggest news of that day: the first day of marijuana legalization in Canada.

America’s slightly more affable and polite neighbor to the north was the second country in the world after Uruguay to allow adults to possess, use, grow, and purchase cannabis — but the first to encourage what could be called “an industry,” welcoming international investors onto to Canadian Stock Exchange, and allowing the construction of titanic greenhouses big enough to get everybody on the continent buzzed.

Canadian actor Seth Rogen, who recently launched his own cannabis brand in partnership with Canopy Growth, believes that the Canadian government should reconsider its strategy against combating the black market for marijuana.

In an interview with The Canadian Press, the Pineapple Express star described Ottawa’s current efforts as “not incredibly helpful if their actual goal is to destroy the black market.”

According to Rogen, people have less incentive to sell weed legally due to the complex and expensive procedure for setting up dispensaries. 

The Canadian marijuana company no longer has confidence in its U.S. CBD assets.

What happened?

Shares of Cronos Group (NASDAQ:CRON) are tumbling 16.5% in morning trading Tuesday after the Canadian marijuana company filed a form 12b-25 with the Securities and Exchange Commission saying it would be unable to file its quarterly earnings report on time. 

Cronos said it needs more time to figure out just how big of an impairment charge it's going to take on its cannabidiol (CBD) business, but it's going to take a hit of at least $220 million to its goodwill and intangible assets.

 Avicanna Inc. ("Avicanna" or the "Company”) (TSX: AVCN)
(OTCQX: AVCNF) (FSE: 0NN), a Canadian biopharmaceutical company focused on the development of plant-derived, cannabinoid-based products, announced today the distribution of Viola cannabis products across Canada on the Medical Cannabis by Shoppers online platform, a subsidiary of Shoppers Drug Mart Inc.™, Canada’s leading health, beauty, and convenience retailer. The well-established equity focused brand will also be made available across adult use channels including Ontario and New Brunswick imminently.  

The COVID-19 pandemic led to an increase in sales of all kinds of vices, but marijuana purchases increased more than others, a new study suggests.

Researchers from McMaster University in Hamilton, Ontario, Canada gathered sales data of marijuana and alcohol in their city to find if there was a pandemic-related increase in drug sales.

They found that, at the start of the pandemic, there was a surge in sales as many stockpiled marijuana and alcohol. 

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”), a federally regulated producer of cannabis oil that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, announced today the launch of Distilled CBD 100 Oil & Distilled CBD 200 Oil under the Company’s prohibition-era brand Glacial Gold™.

Glacial Gold™ Distilled CBD 200 Oil is a first in Canada’s adult-use and medical markets, with the highest amount of CBD in a single unit (5700 mg), highest potency of CBD available in an ingestible oil format (200 mg/g = 20 %), and best dollar value per milligram for CBD in both the legal and illicit markets in Canada.